HL FINANCIAL SERVICES LLC historic quarter change: Foreign Stocks, Reduced
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, HL FINANCIAL SERVICES LLC opened 12 positions, added to 47, reduced 43 and sold out of 15.
- Q3 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 8,138.
- Q3 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 20,439.
- Q3 2016: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 22,124.
- Q3 2016: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 8,740.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1430233), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-25); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-26); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-26); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-26); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-19); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-28); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-23); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-21); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-27); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-01); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-21); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-24); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-24). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-06-30.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | TEVA
TEVA PHARMACEUTICAL INDS | | ADR | 8,138 | 6,139 | -1,999 | $409,000 | $282,000 | -$127,000 | 2016-10-25 |
|---|
| Q3 2016 | NVS
NOVARTIS AG | | SPONSORED ADR | 20,439 | 20,371 | -68 | $1,686,000 | $1,608,000 | -$78,000 | 2016-10-25 |
|---|
| Q3 2016 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 22,124 | 21,274 | -850 | $1,060,000 | $1,008,000 | -$52,000 | 2016-10-25 |
|---|
| Q3 2016 | DEO
DIAGEO PLC NEW | | SPON ADR NEW | 8,740 | 8,670 | -70 | $987,000 | $1,006,000 | +$19,000 | 2016-10-25 |
|---|
| Q2 2016 | NVS
NOVARTIS AG | | SPONSORED ADR | 20,489 | 20,439 | -50 | $1,484,000 | $1,686,000 | +$202,000 | 2016-07-26 |
|---|
| Q2 2016 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 25,374 | 22,124 | -3,250 | $1,146,000 | $1,060,000 | -$86,000 | 2016-07-26 |
|---|
| Q2 2016 | TEVA
TEVA PHARMACEUTICAL INDS | | ADR | 8,656 | 8,138 | -518 | $463,000 | $409,000 | -$54,000 | 2016-07-26 |
|---|
| Q2 2016 | NVO
NOVO NORDISK AS ADR | | ADR | 8,615 | 8,255 | -360 | $467,000 | $444,000 | -$23,000 | 2016-07-26 |
|---|
| Q1 2016 | NVS
NOVARTIS AG | | SPONSORED ADR | 21,058 | 20,489 | -569 | $1,812,000 | $1,484,000 | -$328,000 | 2016-04-26 |
|---|
| Q1 2016 | DEO
DIAGEO PLC NEW | | SPON ADR NEW | 10,752 | 8,640 | -2,112 | $1,173,000 | $932,000 | -$241,000 | 2016-04-26 |
|---|
| Q1 2016 | NVO
NOVO NORDISK AS ADR | | ADR | 10,145 | 8,615 | -1,530 | $589,000 | $467,000 | -$122,000 | 2016-04-26 |
|---|
| Q1 2016 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 26,275 | 25,374 | -901 | $1,133,000 | $1,146,000 | +$13,000 | 2016-04-26 |
|---|
| Q4 2015 | DEO
DIAGEO PLC NEW | | SPON ADR NEW | 11,413 | 10,752 | -661 | $1,230,000 | $1,173,000 | -$57,000 | 2016-01-26 |
|---|
| Q4 2015 | NVO
NOVO NORDISK AS ADR | | ADR | 11,645 | 10,145 | -1,500 | $632,000 | $589,000 | -$43,000 | 2016-01-26 |
|---|
| Q3 2015 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 31,660 | 26,189 | -5,471 | $1,360,000 | $1,068,000 | -$292,000 | 2015-10-19 |
|---|
| Q3 2015 | IEP
ICAHN ENTERPRISES | United States | DEPOSITARY UNIT | 3,600 | 3,100 | -500 | $312,000 | $208,000 | -$104,000 | 2015-10-19 |
|---|
| Q2 2015 | TEVA
TEVA PHARMACEUTICAL INDS | | ADR | 7,005 | 6,833 | -172 | $436,000 | $404,000 | -$32,000 | 2015-07-28 |
|---|
| Q2 2015 | NVS
NOVARTIS AG | | SPONSORED ADR | 17,477 | 17,321 | -156 | $1,723,000 | $1,703,000 | -$20,000 | 2015-07-28 |
|---|
| Q2 2015 | ULXXXX
UNILEVER PLC | | SPON ADR NEW | 32,907 | 31,660 | -1,247 | $1,373,000 | $1,360,000 | -$13,000 | 2015-07-28 |
|---|
| Q1 2015 | NVS
NOVARTIS AG | | SPONSORED ADR | 17,611 | 17,477 | -134 | $1,632,000 | $1,723,000 | +$91,000 | 2015-04-23 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS | | ADR | 7,976 | 7,005 | -971 | $459,000 | $436,000 | -$23,000 | 2015-04-23 |
|---|
| Q4 2014 | NVS
NOVARTIS AG | | SPONSORED ADR | 21,806 | 17,611 | -4,195 | $2,053,000 | $1,632,000 | -$421,000 | 2015-01-21 |
|---|
| Q4 2014 | SNY
SANOFI SPON ADR | | SPONSORED ADR | 7,531 | 7,323 | -208 | $425,000 | $334,000 | -$91,000 | 2015-01-21 |
|---|
| Q4 2014 | DEO
DIAGEO PLC NEW | | SPON ADR NEW | 7,675 | 7,292 | -383 | $886,000 | $832,000 | -$54,000 | 2015-01-21 |
|---|
| Q3 2014 | PKX
POSCO SPONSORED ADR | | SPONSORED ADR | 6,673 | 3,151 | -3,522 | $497,000 | $239,000 | -$258,000 | 2014-10-27 |
|---|
| Q3 2014 | TELFY
TELEFONICA S A | Spain | SPONSORED ADR | 15,680 | 13,936 | -1,744 | $269,000 | $214,000 | -$55,000 | 2014-10-27 |
|---|
| Q2 2014 | TEVA
TEVA PHARMACEUTICAL INDS | | ADR | 16,590 | 7,200 | -9,390 | $877,000 | $377,000 | -$500,000 | 2014-08-01 |
|---|
| Q2 2014 | PKX
POSCO SPONSORED ADR | | SPONSORED ADR | 8,211 | 6,673 | -1,538 | $570,000 | $497,000 | -$73,000 | 2014-08-01 |
|---|
| Q2 2014 | EC
ECOPETROL S A | | SPONSORED ADS | 9,124 | 8,983 | -141 | $372,000 | $324,000 | -$48,000 | 2014-08-01 |
|---|
| Q2 2014 | SIEGY
SIEMENS A G SPONS ADR | | SPONSORED ADR | 1,988 | 1,788 | -200 | $269,000 | $236,000 | -$33,000 | 2014-08-01 |
|---|
| Q1 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 38,822 | 16,590 | -22,232 | $1,556,000 | $877,000 | -$679,000 | 2014-04-21 |
|---|
| Q1 2014 | DEO
DIAGEO P L C | | SPON ADR NEW | 6,827 | 5,191 | -1,636 | $904,000 | $647,000 | -$257,000 | 2014-04-21 |
|---|
| Q1 2014 | BP
BP PLC | | SPONSORED ADR | 21,424 | 20,265 | -1,159 | $1,041,000 | $975,000 | -$66,000 | 2014-04-21 |
|---|
| Q1 2014 | TELFY
TELEFONICA S A | Spain | SPONSORED ADR | 18,180 | 15,680 | -2,500 | $297,000 | $248,000 | -$49,000 | 2014-04-21 |
|---|
| Q1 2014 | SIEGY
SIEMENS A G | | SPONSORED ADR | 2,038 | 1,988 | -50 | $282,000 | $269,000 | -$13,000 | 2014-04-21 |
|---|
| Q4 2013 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 104,698 | 38,822 | -65,876 | $3,956,000 | $1,556,000 | -$2,400,000 | 2014-01-24 |
|---|
| Q4 2013 | TELFY
TELEFONICA S A | Spain | SPONSORED ADR | 25,180 | 18,180 | -7,000 | $390,000 | $297,000 | -$93,000 | 2014-01-24 |
|---|
| Q4 2013 | PKX
POSCO | | SPONSORED ADR | 8,715 | 7,858 | -857 | $642,000 | $613,000 | -$29,000 | 2014-01-24 |
|---|
| Q3 2013 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 105,871 | 104,698 | -1,173 | $4,150,000 | $3,956,000 | -$194,000 | 2013-10-24 |
|---|
| Q3 2013 | NVS
NOVARTIS A G | | SPONSORED ADR | 9,074 | 8,765 | -309 | $642,000 | $672,000 | +$30,000 | 2013-10-24 |
|---|
| Q3 2013 | SIEGY
SIEMENS A G | | SPONSORED ADR | 2,278 | 1,838 | -440 | $231,000 | $221,000 | -$10,000 | 2013-10-24 |
|---|
| Q3 2013 | PKX
POSCO | | SPONSORED ADR | 9,937 | 8,715 | -1,222 | $647,000 | $642,000 | -$5,000 | 2013-10-24 |
|---|
| Q3 2013 | DEO
DIAGEO P L C | | SPON ADR NEW | 6,770 | 6,157 | -613 | $778,000 | $782,000 | +$4,000 | 2013-10-24 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |